Cargando…

Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry

BACKGROUND: A considerable number of patients undergoing incisional hernia repair are on anticoagulant or antiplatelet therapy or have existing coagulopathy which may put them at higher risk for postoperative bleeding complications. Data about the optimal treatment of these patients are sparse. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Staerkle, Ralph F., Hoffmann, Henry, Köckerling, Ferdinand, Adolf, Daniela, Bittner, Reinhard, Kirchhoff, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096530/
https://www.ncbi.nlm.nih.gov/pubmed/29492708
http://dx.doi.org/10.1007/s00464-018-6127-y
_version_ 1783348120728371200
author Staerkle, Ralph F.
Hoffmann, Henry
Köckerling, Ferdinand
Adolf, Daniela
Bittner, Reinhard
Kirchhoff, Philipp
author_facet Staerkle, Ralph F.
Hoffmann, Henry
Köckerling, Ferdinand
Adolf, Daniela
Bittner, Reinhard
Kirchhoff, Philipp
author_sort Staerkle, Ralph F.
collection PubMed
description BACKGROUND: A considerable number of patients undergoing incisional hernia repair are on anticoagulant or antiplatelet therapy or have existing coagulopathy which may put them at higher risk for postoperative bleeding complications. Data about the optimal treatment of these patients are sparse. This analysis attempts to determine the rate of postoperative bleeding complications following incisional hernia repair and the consecutive rate of reoperation among patients with coagulopathy or receiving antiplatelet and anticoagulant therapy (higher risk group) compared to patients who do not have a higher risk (normal risk group). METHODS: Out of the 43,101 patients documented in the Herniamed Registry who had an incisional hernia repair, 6668 (15.5%) were on anticoagulant or antithrombotic therapy or had existing coagulopathy. The implication of that higher risk profile for onset of postoperative bleeding was investigated in multivariable analysis. Hence, other influential variables were identified. RESULTS: The rate of postoperative bleeding in the higher risk group was 3.9% (n = 261) and significantly higher compared to the normal risk group at 1.6% (n = 564) (OR 2.001 [1.699; 2.356]; p < 0.001). Additionally, male gender, use of drains, larger defect size, open incisional hernia repair, lower BMI, and higher ASA score significantly increased the risk of postoperative bleeding. The rate of reoperations due to postoperative bleeding was significantly increased in the higher risk group compared to the normal risk group (2.4 vs. 1.0%; OR 1.217 [1.071; 1.382]; p = 0.003). Likewise, the postoperative general complication rate (6.04 vs. 3.66%; p < 0.001) as well as the mortality rate (0.46 vs. 0.17%; p < 0.001) were significantly higher in the higher risk group. CONCLUSIONS: Patients with anticoagulant or antiplatelet therapy or existing coagulopathy who undergo incisional hernia repair have a significantly higher risk for onset of postoperative bleeding. The risk of bleeding complications and complication-related reoperations seems to be lower after laparoscopic intraperitoneal onlay mesh. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00464-018-6127-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6096530
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-60965302018-08-24 Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry Staerkle, Ralph F. Hoffmann, Henry Köckerling, Ferdinand Adolf, Daniela Bittner, Reinhard Kirchhoff, Philipp Surg Endosc Article BACKGROUND: A considerable number of patients undergoing incisional hernia repair are on anticoagulant or antiplatelet therapy or have existing coagulopathy which may put them at higher risk for postoperative bleeding complications. Data about the optimal treatment of these patients are sparse. This analysis attempts to determine the rate of postoperative bleeding complications following incisional hernia repair and the consecutive rate of reoperation among patients with coagulopathy or receiving antiplatelet and anticoagulant therapy (higher risk group) compared to patients who do not have a higher risk (normal risk group). METHODS: Out of the 43,101 patients documented in the Herniamed Registry who had an incisional hernia repair, 6668 (15.5%) were on anticoagulant or antithrombotic therapy or had existing coagulopathy. The implication of that higher risk profile for onset of postoperative bleeding was investigated in multivariable analysis. Hence, other influential variables were identified. RESULTS: The rate of postoperative bleeding in the higher risk group was 3.9% (n = 261) and significantly higher compared to the normal risk group at 1.6% (n = 564) (OR 2.001 [1.699; 2.356]; p < 0.001). Additionally, male gender, use of drains, larger defect size, open incisional hernia repair, lower BMI, and higher ASA score significantly increased the risk of postoperative bleeding. The rate of reoperations due to postoperative bleeding was significantly increased in the higher risk group compared to the normal risk group (2.4 vs. 1.0%; OR 1.217 [1.071; 1.382]; p = 0.003). Likewise, the postoperative general complication rate (6.04 vs. 3.66%; p < 0.001) as well as the mortality rate (0.46 vs. 0.17%; p < 0.001) were significantly higher in the higher risk group. CONCLUSIONS: Patients with anticoagulant or antiplatelet therapy or existing coagulopathy who undergo incisional hernia repair have a significantly higher risk for onset of postoperative bleeding. The risk of bleeding complications and complication-related reoperations seems to be lower after laparoscopic intraperitoneal onlay mesh. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00464-018-6127-y) contains supplementary material, which is available to authorized users. Springer US 2018-02-28 2018 /pmc/articles/PMC6096530/ /pubmed/29492708 http://dx.doi.org/10.1007/s00464-018-6127-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Staerkle, Ralph F.
Hoffmann, Henry
Köckerling, Ferdinand
Adolf, Daniela
Bittner, Reinhard
Kirchhoff, Philipp
Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry
title Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry
title_full Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry
title_fullStr Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry
title_full_unstemmed Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry
title_short Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry
title_sort does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? data from the herniamed registry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096530/
https://www.ncbi.nlm.nih.gov/pubmed/29492708
http://dx.doi.org/10.1007/s00464-018-6127-y
work_keys_str_mv AT staerkleralphf doescoagulopathyanticoagulantorantithrombotictherapymatterinincisionalherniarepairdatafromtheherniamedregistry
AT hoffmannhenry doescoagulopathyanticoagulantorantithrombotictherapymatterinincisionalherniarepairdatafromtheherniamedregistry
AT kockerlingferdinand doescoagulopathyanticoagulantorantithrombotictherapymatterinincisionalherniarepairdatafromtheherniamedregistry
AT adolfdaniela doescoagulopathyanticoagulantorantithrombotictherapymatterinincisionalherniarepairdatafromtheherniamedregistry
AT bittnerreinhard doescoagulopathyanticoagulantorantithrombotictherapymatterinincisionalherniarepairdatafromtheherniamedregistry
AT kirchhoffphilipp doescoagulopathyanticoagulantorantithrombotictherapymatterinincisionalherniarepairdatafromtheherniamedregistry